Tapasree Roy Sarkar

Institut thématique Génétique, génomique et bioinformatique — France

Medicine · Health Sciences

18h-index1.5kcitations51works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(25), FOXO transcription factor regulation(10), Epigenetics and DNA Methylation(6), Cancer-related molecular mechanisms research(5), Cancer, Hypoxia, and Metabolism(5)

Publications51 total

Distinctive features of cancer-associated fibroblasts expressing CD105, a novel biomarker for bone metastasis, in early-stage invasive ductal breast cancer
Frontiers in Endocrinology·2026Open Access
LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway
Oncogene·2025· 1 citedOpen Access
Corrigendum to “2D Nanosilicate for additive manufacturing: Rheological modifier, sacrificial ink and support bath Bioprinting” [Bioprinting 25 (2022) e00187]
Bioprinting·2025
Editorial: The role of cancer associated fibroblast (CAF) in EMT/metastasis in malignancies of epithelial tissues
Frontiers in Cell and Developmental Biology·2024· 1 citedOpen Access
Supplementary Figure 3 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 3 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 4 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 1 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Data from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Data from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 2 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Materials and Methods from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 4 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 1 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Figure 2 from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
Supplementary Materials and Methods from FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
2023Open Access
The Cytotoxicity of Carbon Nanotubes and Hydroxyapatite, and Graphene and Hydroxyapatite Nanocomposites against Breast Cancer Cells
Nanomaterials·2023· 9 citedOpen Access
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Frontiers in Cell and Developmental Biology·2023· 109 citedOpen Access
Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection
Biomedicine & Pharmacotherapy·2022· 50 citedOpen Access
2D Nanosilicate for additive manufacturing: Rheological modifier, sacrificial ink and support bath
Bioprinting·2022· 17 cited
page 1 of 3Next →

Frequent Co-authors

Nathalie Sphyris(22), Sendurai A. Mani(22), Steven J. Werden(19), Joseph H. Taube(19), Jeffrey T. Chang(17), Naoyuki Miura(17), Jeffrey M. Rosen(17), Maryam Shariati(16), Brett G. Hollier(15), Venkata Lokesh Battula(15), Agata A. Tinnirello(14), Kurt W. Evans(14), Sreedevi V. Kumar(14), Rudy Guerra(14), Jason I. Herschkowitz(13), Geraldine V. Vijay(5), Rama Soundararajan(5), Bani K. Mallick(5), Esmeralda Ramirez‐Peña(4), Weston W. Porter(4)